Maynard, MA, United States of America

Gregory John Carven

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 622(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Gregory J Carven - Innovator in Antibody Development

Introduction

Gregory J Carven is a noteworthy inventor based in Maynard, MA, renowned for his contributions to the field of biotechnology, specifically in the development of antibodies for therapeutic purposes. With a total of two patents to his name, his work aims to address significant medical challenges, particularly bleeding disorders and the modulation of immune responses.

Latest Patents

Carven's most recent patents highlight his innovative spirit and dedication to advancing healthcare. The first patent, titled "Tissue factor pathway inhibitor antibodies and uses thereof," focuses on antibodies and antigen-binding fragments that specifically bind to tissue factor pathway inhibitor (TFPI). This invention offers potential solutions for treating bleeding disorders by inhibiting TFPI activity and shortening clotting time. His second patent, "Isoform-selective TGFB1 inhibitors and use thereof," discloses monoclonal antibodies designed to selectively inhibit TGFβ1 with high potency. This technology presents promising methods and compositions for therapeutic use to effectively manage various conditions.

Career Highlights

Throughout his professional journey, Gregory Carven has been associated with prominent organizations, contributing his expertise to companies such as Scholar Rock, Inc. and Pfizer Corporation. His experience in these leading biotechnology and pharmaceutical firms has shaped his innovative outlook and enabled him to pursue impactful research.

Collaborations

Collaboration is key in the innovation process, and Gregory J Carven has had the opportunity to work with talented colleagues, including Abhishek Datta and Allan Capili. These collaborations have fostered a creative environment where groundbreaking ideas can flourish.

Conclusion

Gregory J Carven stands out as an influential figure in the field of antibody research. His patents not only signify his innovative contributions but also reflect his commitment to improving patient outcomes through scientific advancements. As he continues to push the boundaries of biotechnology, his work will undoubtedly have a lasting impact on the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…